Table 2.
Analyte | Electrode/Modification | Receptor | Matrix/Solvent | LOD (ng/mL) | Linear Range (ng/mL) | Ref. |
---|---|---|---|---|---|---|
CRP | Standard polycrystalline gold electrode modified with SAM immunosensor | Goat anti-human CRP polyclonal antibody | Pharmaceutical preparation, human serum | 0.135 | 0.384–38.4 | [90] |
CRP | Wave shaped microelectrode array with a monolayer functionalized by NaBH4 to anchor antibodies | Human CRP antibody | PBS serum | 0.025–0.23 | 0.01 – 10 × 103 | [89] |
CRP | Screen printed graphene electrode functionalized by l-cystine and gold to anchor Anti-1°Ab | Anti-1°Ab unlabeled capture antibody & Anthraquinone labelled anti-human CRP secondary antibody |
Human serum | 1.5 | 10 – 150 × 103 | [91] |
CRP | Reduced graphene oxide (rGO)-modified screen-printed carbon electrode (SPCE) functionalized via 1-pyrenebutyric acid N hydroxy succinimide ester (PyNHS) | Anti-CRP antibody | Pharmaceutical preparation | – | 10 – 1 × 104 | [92] |
CRP | Branched polyethylenimine functionalized with ferroced residues recognition layer anchored to electrode surface for the covalent anchoring of antibodies | Monoclonal IgG anti CRP antibodies | Rat blood | 0.5–2.5 | 1 – 5 × 104 | [93] |
CRP | Gold printed screened electrode has affinity for sulfur and nitrogen, which allows for antibodies to covalently attach | Monoclonal anti-CRP antibody | Human serum | 780 | 6.25 × 103–5 × 104 | [94] |
CRP | Disposable single walled carbon nanotubes field effect transistor immunosensor, able to absorb amino groups in anti-CRP antibodies | Goat anti-CRP | Pharmaceutical preparation | 0.1 | 0.1 – 1 × 105 | [95] |